Researchers explored the potential impact of more than 100 risk factors on a person's risk of sudden cardiac arrest. Some of their findings were what you may expect, but others were much more surprising.

Researchers examined data from more than 9,000 patients, sharing their findings at SCAI 2025.

As time goes on, the gaps between the healthiest states and the least healthy states are only getting wider and wider. "Our findings highlight the urgent need for targeted strategies to reduce state-based inequities in cardiometabolic risk factors,” researchers wrote. 

"These results highlight semaglutide’s early action on decreasing major cardiovascular events," one cardiologist explained.

Researchers shared new studies on the highly selective CETP inhibitor in The New England Journal of Medicine and The Lancet.

New data out of Sweden show that using Abbott's continuous glucose monitor technology is associated with a reduced risk of being hospitalized for cardiac complications. This was true for patients with and without a history of prior heart disease.

Cannabis use can be especially harmful for heart failure patients, according to new data presented at SCAI 2025.

Two of the world's leading medtech companies have been collaborating to improve patient access to CGM technology. It now looks like Medtronic and Abbott could be close to gaining FDA clearance and moving forward to the next phase of their partnership.

Researchers evaluated data from more than 273,000 patients with a history of ASCVD, noting that higher Lp(a) levels are consistently linked to worse cardiovascular outcomes.

Both operations can help obese patients lose weight, researchers noted, but gastric bypass surgery "may be associated with greater cardiovascular benefits."